Clinical Trial Update: Mucin Concentration in Sputum From COPD Patients During a Pulmonary Exacerbation

View source ↗

Summary

This clinical trial investigating mucin concentration in sputum from COPD patients during a pulmonary exacerbation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Philipps University Marburg | Conditions: COPD | Status: WITHDRAWN